期刊文献+

星点设计-效应面法优化葫芦素B纳米脂质载体处方 被引量:7

Optimization of Preparation of Nanostructured Lipid Carriers Loaded with Cucurbitacin B by Central Composite Design and Response Surface Methodology
原文传递
导出
摘要 用熔融-乳化法制备葫芦素B纳米脂质载体,以平均粒径、包封率和载药量为评价指标,采用星点设计-效应面法优化处方。所得优化处方为单硬脂酸甘油酯0.3 g、卵磷脂0.125 g、注射用大豆油0.075 g、聚乙二醇40硬脂酸酯0.2 g。优化处方平均粒径、包封率和载药量的实测值分别为120.8 nm、83.3%和0.83%,并与预测值相近。制品在45.5 h时体外释放率可达(87.1±3.5)%,且体外释放行为符合一级动力学模型。 The nanostructured lipid carriers loaded with cucurbitacin B were prepared by melt-emulsification method.Central composite design-response surface methodology (CCD-RSM) was utilized to optimize the formulation with average particle size,entrapment efficiency and drug loading as evaluation indexes.The optimal formulation was as follows:glycerin monostearate was 0.3 g,lecithin was 0.125 g,soybean oil of injection was 0.075 g and polyethylene glycol 40 stearate was 0.2 g.The measured values of average particle size,entrapment efficiency and drug loading for the optimal product were 120.8 nm,83.3 % and 0.83 %,respectively.And these measured values were close to the predicted values.The cumulative amount at 45.5 h was (87.1±3.5) % and the first-order kinetic model gave a good fit to the in vitro release data.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第11期1042-1045,1077,共5页 Chinese Journal of Pharmaceuticals
基金 黑龙江省教育厅面上项目资助(12531787)
关键词 葫芦素B 纳米脂质载体 星点设计-效应面优化法 cucurbitacin B nanostructured lipid carrier(NLC) central composite design-response surface methodology (CCD-RSM)
  • 相关文献

参考文献14

二级参考文献66

共引文献76

同被引文献80

  • 1曹健,张诗龙,刘军,王伊文.复方丹参片中七种主要成分的HPLC法测定[J].中国医药工业杂志,2011,42(5):365-367. 被引量:6
  • 2杨翠红,张玉民,刘金剑,刘鉴峰,吴红英,褚丽萍.RGD功能化多肽纳米纤维的制备及其体内肿瘤靶向性研究[J].中国生化药物杂志,2014,34(5):5-8. 被引量:3
  • 3陈信义,高志捷,王玉芝.薯蓣皂苷抗移植性小鼠乳腺癌作用的研究[J].中国中医药信息杂志,2005,12(5):23-24. 被引量:22
  • 4杨婉华,汪蕊,陈睿,马湘一,王世宣,卢运萍,马丁.αv整联蛋白拮抗剂RGD肽对乳腺癌细胞增殖侵袭能力影响的研究[J].肿瘤,2006,26(8):728-731. 被引量:3
  • 5Nishiyama N, Kataoka K. Cun~nt state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene de- livery. [J]. Pharmacol Ther, 2006, 112(3) : 630-648.
  • 6Shen J, Yin Q, Chen L, et al. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to over- come drug resistance in lung cancer [ J ]. Biomaterials, 2012, 33 (33) :8613-8624.
  • 7Liang Y, Su Z, Yao Y, et al. Preparation of pH sensitive Plumnic- Docetaxel conjugate micelles to balance the stability and controlled re- lease issues [ J]. Materials, 2015, 8(2): 379-391.
  • 8Sezgin Z, Yilksel N, Baykara T. Preparation and characterization of polymeric mieclles for solubilization of poorly soluble anticancer drugs [J]. Eur J Pharm Biopharm , 2006, 64(3): 261-268.
  • 9Dou J, Zhang H, Liu X, et al. Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration [ J ]. Colloids Su9r B Biointe~faces, 2014, 114( 1 ) : 20-27.
  • 10Müller R H,Radtke M,Wissing S A.Nanostructured lipid matrices for improved microencapsulation of drugs[J].Int J Pharm,2012,242(1-2):121-128.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部